Clinical Trend of the Week (July 15-21): Ketamine
A new study that may lead to the development of safer alternatives for a psychoactive drug is responsible for this week's top search term. Results published in Nature found that ketamine blocks the N-methyl-D-aspartate receptor (NMDAR), allowing for an initial antidepressant effect. The study also found that the ketamine metabolite hydroxynorketamine (HNK) may extend the length of the antidepressant effect, which could help in the quest for safer alternatives. These findings are somewhat in conflict with another recent study, meaning further investigation is needed in order to provide a safe treatment for individuals with depression.
For more information on depression, read here.
Medscape © 2017
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ryan Syrek. Clinical Trends for July 2017 - Medscape - Jul 28, 2017.